Levitra
Product Images NDC 43353-748

11 FDA label images from Aphena Pharma Solutions - Tennessee, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levitra (NDC 43353-748). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vardenafil HCl (levitra) 10mg Tablets (43353 741)

Vardenafil HCl (levitra) 10mg Tablets (43353 741)
Label for Levitra 10 mg tablets containing Vardenafil HCl, repackaged by Aphena Pharma Solutions - Tennessee, Inc. The label indicates a package size of 2 tablets and notes original manufacturing by Bayer Healthcare Pharmaceuticals Inc, Wayne, NJ. Storage instructions and barcodes are also present.*
FDA Label Image

Vardenafil HCl (levitra) 5mg Tablets (43353 744)

Vardenafil HCl (levitra) 5mg Tablets (43353 744)
Label for Levitra, containing vardenafil HCl 5mg tablets, packaged as 2 tablets per container. Manufactured by Bayer Healthcare Pharmaceuticals Inc in Wayne, NJ, and repackaged by Aphena Pharma Solutions - Tennessee, Inc. in Cookeville, TN. The label includes storage instructions and states the product is RX only.*
FDA Label Image

Vardenafil HCl (levitra) 20mg Tablets (43353 748)

Vardenafil HCl (levitra) 20mg Tablets (43353 748)
Packaging label for Levitra showing Vardenafil HCl 20mg tablets. The label indicates a quantity of 2 tablets and notes the product is repackaged by Aphena Pharma Solutions - Tennessee, Inc. It also states the original manufacturer as Bayer Healthcare Pharmaceuticals Inc. The label includes storage instructions and barcodes.*
FDA Label Image

Structural Formula (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 01)

Structural Formula (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 01)
Chemical structure diagram showing the molecular formula of the active ingredient in Levitra, including its hydrochloride and trihydrate components.*
FDA Label Image

Figure 1 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 02)

Figure 1 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 02)
A pharmacokinetic curve depicting plasma concentration (µg/L) versus time (hours) after dosing. The graph shows a rapid increase in plasma concentration peaking early, followed by a decline over 24 hours with error bars at each time point to indicate variability.*
FDA Label Image

Figure 2 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 03)

Figure 2 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 03)
A set of three line graphs depicting mean maximal changes in systolic blood pressure, diastolic blood pressure, and heart rate over time. Each graph shows data points with error bars at intervals labeled 24h, 8h, 4h, and 1h, corresponding to timing of Vardenafil treatment pre-NTG. The graphs illustrate trends in cardiovascular parameters during the observation period.*
FDA Label Image

Figure 3 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 04)

Figure 3 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 04)
Line graph displaying mean change in mmHg over 6 hours, comparing placebo and Vardenafil 5 mg and 6 mg under simultaneous and 6-hour separation conditions. The x-axis shows time in hours, and the y-axis shows mean change in mmHg.*
FDA Label Image

Figure 4 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 05)

Figure 4 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 05)
A line graph depicting mean change in mmHg over time in hours for four groups: Placebo simultaneous, Vardenafil 5 mg simultaneous, Placebo 8-hour separate, and Vardenafil 5 mg 8-hour separate. The graph shows varying pressure changes across a 6-hour period for each group.*
FDA Label Image

Figure 5 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 06)

Figure 5 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 06)
A line graph showing mean change in mmHg over time (hours) comparing placebo (stage 1 and stage 2) and Vardenafil at 10 mg and 20 mg doses. The graph illustrates the blood pressure response across a 6-hour period.*
FDA Label Image

Figure 6 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 07)

Figure 6 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 07)
A line graph titled Terazosin showing mean change in mmHg over time in hours. Multiple lines represent different groups including placebo, 10 mg Vardenafil, and 20 mg Vardenafil, both with and without 8-hour separation or combined with Simblastoluc, showing changes in blood pressure over a 6-hour period.*
FDA Label Image

Figure 7 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 08)

Figure 7 (A01def95 C0ef 43b9 Bd9e 5565b2385ad3 08)
A line graph titled 'TAMSULOSIN' showing mean change in mmHg over time in hours. It compares placebo versus 10 mg and 20 mg doses of Vardenafil, administered either separately or simultaneously with another variable, across different time points up to 6 hours.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.